Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LLY vs MRNA✓SelectedUSD · MRNALLY vs MRNA performance historyLatest closeAs of+1.26%11/13
Stock and ETF performance explorer

LLY vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,305.4%
MRNA return
+915.3%
Excess return
+390.1%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.3%-3.4%+4.7%+1.4%
7D+6.7%-12.1%+18.9%+7.3%
30D+19.6%-1.3%+20.9%+19.4%
3M+19.7%+250.9%-231.2%+9.6%
6M+42.7%+343.0%-300.3%+28.6%
YTD+35.1%+657.4%-622.3%+17.9%
1Y+42.2%+794.9%-752.7%+22.8%
3Y+140.8%+218.1%-77.4%+112.5%
5Y+480.6%-3.4%+484.0%+431.1%
All+1,305.4%+915.3%+390.1%+973.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling